National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050 2024

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial 2024

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis 2024

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial 2021

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial 2020

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial 2019

Insulin dosing guidance to optimise type 2 diabetes management - authors' reply 2019

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial 2018

Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial 2017

Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial 2011

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial 2010

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial 2010

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial 2010

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) 2009

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study 2008

Should the internet be used to promote healthy living? 2007

Sickle cell trait: an unsound cause of death [editorial].  398. 2021

COVID-19 trial co-enrolment and subsequent enrolment [editorial].  396. 2020

Continuous glucose monitoring: transforming diabetes management step by step [editorial].  391. 2018

Tranexamic acid: is it about time [editorial]?.  391. 2018

Milestones in treatment: the tipping point and the ResQ Trial [editorial].  377. 2011

Migrants, detainees, and misconceptions [editorial].  373. 2009

Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain [editorial].  1. 1985

Advances in technology for management of type 1 diabetes [review] 2019

0140-6736

1474-547X